SCHEMBL25157589

SCHEMBL25157589

c1ncc2cc(-c3c[nH]c4nc(NCC5CCCCC5)ncc34)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 2/20 0.48
▸ ROCK2 O75116 3/20 0.45
▸ CDC7 O00311 2/20 0.45
▸ MAP4K4 O95819 2/20 0.45
▸ CCNB2 O95067 1/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ RET P07949 1/20 0.45
▸ CCNB1 P14635 1/20 0.45
▸ PRKACA P17612 1/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ GSK3B P49841 1/20 0.45
▸ CCNB3 Q8WWL7 1/20 0.45
▸ HIPK2 Q9H2X6 1/20 0.45
▸ MKNK2 Q9HBH9 1/20 0.45
▸ IRAK4 Q9NWZ3 1/20 0.45
▸ DYRK1A Q13627 3/20 0.42
▸ CLK2 P49760 2/20 0.39
▸ CLK3 P49761 2/20 0.39
▸ BRD4 O60885 2/20 0.38
▸ KCNH2 Q12809 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25157442 0.89 DYRK1A (0.47) TDO2ROCK2CDK1CDK2DYRK1A
SCHEMBL30347639 0.89 DYRK1A (0.47) TDO2ROCK2CDK1CDK2DYRK1A
SCHEMBL25157439 0.89 TDO2 (0.45) TDO2ROCK2CDC7MAP4K4CCNB2
SCHEMBL25156980 0.85 TDO2 (0.51) TDO2ROCK2CDC7MAP4K4CCNB2
SCHEMBL30347844 0.83 TDO2 (0.55) TDO2GSK3BDYRK1ACLK2CLK3
SCHEMBL25156876 0.83 TDO2 (0.55) TDO2GSK3BDYRK1ACLK2CLK3
SCHEMBL25519953 0.81 TDO2 (0.51) TDO2ROCK2DYRK1ACLK2CLK3
SCHEMBL30407103 0.81 TDO2 (0.47) TDO2GSK3BDYRK1ACLK2CLK3
SCHEMBL30348811 0.81 TDO2 (0.47) TDO2ROCK2GSK3BDYRK1ACLK2
SCHEMBL25157097 0.81 TDO2 (0.47) TDO2ROCK2GSK3BDYRK1ACLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023064361-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO disclosed
Send feedback